European Patent Office

T 1114/20 (Process for hemostatic compositions / BAXTER) vom 13.06.2023

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2023:T111420.20230613
Datum der Entscheidung
13. Juni 2023
Aktenzeichen
T 1114/20
Antrag auf Überprüfung von
-
Anmeldenummer
11724602.5
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS
Name des Antragstellers
Baxter International Inc.
Baxter Healthcare S.A.
Name des Einsprechenden
Ethicon Inc.
Ferrosan Medical Devices A/S
Kammer
3.3.07
Leitsatz
-
Relevante Rechtsnormen
European Patent Convention Art 100(a)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84European Patent Convention R 80Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Schlagwörter
Argument and item of evidence filed during appeal proceedings - admittance (yes)
Admittance of (late-filed) requests - auxiliary requests 18, 19, 22, 23 (yes)
Admittance of (late-filed) requests - auxiliary requests 9 (15:10), 10 (18:00), 14 to 17, 21, 24 to 26 (no)
Novelty - main request and auxiliary requests 1 to 4, 11 to 13, 18, 19 (no)
Inventive step - auxiliary request 5 (11:00), 9 (16:10), 20, 22, 23 (no)
Claims - clarity
Claims - auxiliary requests 6 to 8 (no)
Amendment occasioned by ground for opposition - auxiliary request 10 (no)
Orientierungssatz
-
Zitierende Akten
-

Order

For these reasons it is decided that:

The appeal is dismissed.